Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07878065

Artistic and Movement Activities to Reduce Anxiety in Children With Acute Lymphoblastic Leukemia.

Conditions: Anxiety, Acute Leukemia

Sex: All
Ages: 8 Years – 13 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 76
Sponsor: Children's Cancer Hospital Egypt 57357

Location: Children's cancer hospital 57357 Cairo Cairo Governorate

Summary

The goal of this clinical trial is to evaluate whether a combined artistic and motor activity program can reduce anxiety in children aged 8-13 with acute lymphoblastic leukemia (ALL) undergoing chemotherapy at Children's Cancer Hospital Egypt 57357. The main questions it aims to answer are: * Does participation in the program reduce anxiety compared to standard care? * Does the program improve psychological well-being, social interaction, and coping during treatment? Researchers will compare an experimental group (receiving the artistic and motor program) with a control group (receiving standard care only) to see if the intervention lowers anxiety scores on the Spence Children's Anxiety Scale. Participants will: * Be randomly assigned to either the experimental or control group. * Complete pre- and post-intervention anxiety assessments. In the experimental group: * Attend 16 weekly sessions over 4 months. * Participate in art workshops (drawing, coloring, group activities). * Engage in motor activities (warm-up, progressive exercises, relaxation, light games, treadmill/cycling up to 5 minutes). In the control group: Will not be exposed to the program, with anxiety measured before and after the same period.

Eligibility Criteria

Inclusion Criteria: * Age from 8 to 13 years old as recorded in the hospital's official records. * Children who experience feelings of anxiety. * Medical fitness of the patient (confirmed through medical examination under the supervision of the specialist physician) before implementing the physical abilities program. * Being in the third stage of the treatment protocol. Exclusion Criteria: * Cases that are already under follow-up with the psychiatric clinic. * Cases that miss 4 sessions of the program. * Cases that do not suffer from anxiety.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07878065). StuddyBuddy aggregates publicly available trial information.